Considering the importance of the FGF19/ELF4/FGFR4 positive feedback circuit in CRC metastasis, we attempted to develop a novel therapeutic strategy to break this loop and achieve satisfactory clinical results. This evidence concerns the gene ELF4 and colorectal carcinoma.